可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]姜晓宇,赵晓云,张东海.慢性心力衰竭患者20年内病因构成及病死率的变化[J].心脏杂志,2013,25(6):677-679.
[2]王 浩,李 霞,磷良毅.降钙素原与白介素-6与急性心力衰竭继发肺部感染的关系[J].心脏杂志,2014,25(3):323-326.
[3]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(1):98-101.
[4]徐沙丽,李中明,廖 冰.医院感染现患率调查分析[J].中华医院感染学杂志,2010,20(17):2570-2573.
[5]Heper Y,Akalin EH,Mistik R,et al.Evaluation of serum C-reative protien, procalcionin,tumor necrosis factor alpha,and interleukin-10 levels in diagnostic and prognostic parameters in patients with commrnity-acquired sepsis,severs sepsis,and septic shock[J].Eur J Clin Microbiol Infect Dis,2006,25(8):481-491.
[6]Zimmerman MA,Selzman CH,Cothern C,et al.Diagnostic implication of C-reative protien[J].Arch Surg,2001,138(2):220-224.
[7]Kruif MD,Limper M,Gerritsen H,et al.Additional value of procalcitonin for diagnosis of infection in patients with fever at emergency department[J].Crit Care Med,2010,38(2):457-463.
[8]Sarbinowski R,Arvidsson S,Tylman M,et al.Plasma concentration of procalcitionin and systemic inflammatory response sysdrome[J].Acta Anaesthesiol Seand,2005,49(2):191-196.
[9]Luzzani A,Pulati E,Dorizzi R,et al.Comparison of procalcitonin and C-reactive protein as markers of sepsis[J].Crit Care Med,2003,31(6):1737-1741.